Does INFLIXIMAB Cause Nephrolithiasis? 981 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 981 reports of Nephrolithiasis have been filed in association with INFLIXIMAB (Renflexis). This represents 0.7% of all adverse event reports for INFLIXIMAB.
981
Reports of Nephrolithiasis with INFLIXIMAB
0.7%
of all INFLIXIMAB reports
6
Deaths
410
Hospitalizations
How Dangerous Is Nephrolithiasis From INFLIXIMAB?
Of the 981 reports, 6 (0.6%) resulted in death, 410 (41.8%) required hospitalization, and 7 (0.7%) were considered life-threatening.
Is Nephrolithiasis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INFLIXIMAB. However, 981 reports have been filed with the FAERS database.
What Other Side Effects Does INFLIXIMAB Cause?
Off label use (34,801)
Drug ineffective (33,738)
Condition aggravated (16,616)
Rheumatoid arthritis (16,251)
Pain (15,061)
Fatigue (13,473)
Arthralgia (13,441)
Infusion related reaction (12,946)
Product use issue (12,752)
Drug intolerance (11,173)
What Other Drugs Cause Nephrolithiasis?
ADALIMUMAB (2,416)
ETANERCEPT (1,292)
METHOTREXATE (979)
ABATACEPT (788)
TOPIRAMATE (768)
CERTOLIZUMAB PEGOL (735)
RITUXIMAB (709)
TOFACITINIB (699)
SODIUM OXYBATE (698)
PREDNISONE (694)
Which INFLIXIMAB Alternatives Have Lower Nephrolithiasis Risk?
INFLIXIMAB vs INFLIXIMAB-ABDA
INFLIXIMAB vs INFLIXIMAB-AXXQ
INFLIXIMAB vs INFLIXIMAB-DYYB
INFLIXIMAB vs INFLIXIMAB-QBTX
INFLIXIMAB vs INFLIXIMAB, RECOMBINANT